Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum.
about
The type IV leader peptidase/N-methyltransferase of Vibrio vulnificus controls factors required for adherence to HEp-2 cells and virulence in iron-overloaded miceIdentification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus.Pathogenesis of infection by clinical and environmental strains of Vibrio vulnificus in iron-dextran-treated mice.Immunogenicity of Vibrio vulnificus capsular polysaccharides and polysaccharide-protein conjugatesPhage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated miceCapsular polysaccharide-protein conjugate vaccines of carbotype 1 Vibrio vulnificus: construction, immunogenicity, and protective efficacy in a murine modelPreclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus.Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro modelsHepcidin: the missing link between hemochromatosis and infections.The pyrH gene of Vibrio vulnificus is an essential in vivo survival factor.Vibrio vulnificus damages macrophages during the early phase of infection.Roles of RseB, sigmaE, and DegP in virulence and phase variation of colony morphotype of Vibrio vulnificus.Use of a marker plasmid to examine differential rates of growth and death between clinical and environmental strains of Vibrio vulnificus in experimentally infected mice.Role of the protease in the permeability enhancement by Vibrio vulnificus.
P2860
Q31968540-4296B700-5C87-40AE-9E01-68922933C1E4Q33552913-BF442432-4600-4461-B01E-89068F16B23DQ33592288-1613E616-E498-4548-80DA-5737267059E2Q33596872-C473C9C0-85D8-4378-9BA2-55FF83E31C4AQ34181298-1E50F883-F351-43A7-8EEC-C67AB74D1A18Q35427366-95D3606B-4C61-400F-84DE-BEDA43B974FDQ35499121-8E833790-4513-4057-A712-01344F9A1ECAQ35554995-33607679-9B24-4D59-BD1E-D8940B585F50Q35593166-478514B6-2314-4B63-AB16-074B36125ACFQ35913420-B5FF56DC-C6DF-4BFF-91BB-1FDDAB982D83Q35947196-217511AF-8BDE-4C45-AC8E-FCAE9044FD86Q37333428-06E214EA-F52F-47E0-83BF-CB8D1033EB53Q53610077-9A9E4595-0DCB-4CFF-B4F9-B014562707C5Q53870920-51206CD6-5182-45BE-A671-644D370869B1
P2860
Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Inhibitory effect of capsular ...... cidal activity of human serum.
@en
Inhibitory effect of capsular ...... cidal activity of human serum.
@nl
type
label
Inhibitory effect of capsular ...... cidal activity of human serum.
@en
Inhibitory effect of capsular ...... cidal activity of human serum.
@nl
prefLabel
Inhibitory effect of capsular ...... cidal activity of human serum.
@en
Inhibitory effect of capsular ...... cidal activity of human serum.
@nl
P2093
P2860
P1476
Inhibitory effect of capsular ...... cidal activity of human serum.
@en
P2093
P2860
P304
P356
10.1111/J.1348-0421.1987.TB03102.X
P577
1987-01-01T00:00:00Z